News
Merck, contract research firm IRBM partner on coronavirus therapies
Merck (MSD) has collaborated with contract research services company IRBM for the identification and development of new peptide therapeutics that can target various strains of coronavirus, including SARS-CoV-2.
The alliance will work on hit to lead optimisation and preclinical development...
News
Gilead Sciences to Acquire Tizona Therapeutics for $300 Million
Gilead Sciences, Inc. announced that it will invest $300 million to acquire a 49.9 percent equity interest in Tizona Therapeutics, Inc., a privately held company developing first-in-class cancer immunotherapies. Gilead will also receive an exclusive option to acquire the...
Clinical Trials
SGS to provide analytical testing for AstraZenecas Covid-19 vaccine
SGS will provide its services to support the development of AstraZeneca’s Covid-19 vaccine candidate – AZD1222 – which was co-invented by the University of Oxford and its spin-out company Vaccitech. The vaccine is currently undergoing human trials in a...
News
Csafe Global appoints new Latin America director
CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced that Denis Caputo has officially joined the company as Director of Life Science Sales – Latin America.
CSafe has been building its worldwide...
News
Hyderabad Airport enhances cold chain with mutli-ULD cool dolly
India’s GMR Hyderabad International Airport (GHIAL) has started using a multi-ULD cool dolly for the transportation of temperature- and time-sensitive shipments such as pharma and perishable cargo.
Comprising of a steel trailer and an aluminium insulated container, the cool dolly...
News
Thermo Fisher Scientific further strengthen its Global Response to COVID-19 to Support Development and Production of Therapeutics and Vaccines
Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines,...
News
Synairgen Releases Positive Results from Breakthrough Coronavirus Treatment
Synairgen, the respiratory drug discovery and development company which originated from research at the University of Southampton, has released positive results from its clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalized COVID-19 patients.
"We are...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read